About Concord Biotech
Concord Biotech is a company based in Ahmedabad (India) founded in 2000 by Ankur Vaid.. The company has 1,570 employees as of March 31, 2024. Concord Biotech offers products and services including APIs, Formulations, and Contract Research and Manufacturing. Concord Biotech operates in a competitive market with competitors including Almac Group, Indoco Remedies, BDR Pharmaceuticals Internationals, Aurobindo Pharma and Asymchem, among others.
- Headquarter Ahmedabad, India
- Employees 1570 as on 31 Mar, 2024
- Founders Ankur Vaid
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Concord Biotech Ltd.
-
Annual Revenue
$137.85 M (USD)18.21as on Mar 31, 2024
-
Net Profit
$43.46 M (USD)20.62as on Mar 31, 2024
-
EBITDA
$57.94 M (USD)18.24as on Mar 31, 2024
-
Latest Funding Round
-
Investors
Quadria Capital
& 2 more
-
Employee Count
1570
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Concord Biotech
Concord Biotech is a publicly listed company on the NSE with ticker symbol CONCORDBIO in India, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Concord Biotech
Concord Biotech offers a comprehensive portfolio of products and services, including APIs, Formulations, and Contract Research and Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Manufactures fermentation and semi-synthetic APIs for therapeutic segments.
Produces nephrology and critical care formulations for global markets.
Offers formulation development and manufacturing services for APIs.
Unlock access to complete
Funding Insights of Concord Biotech
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2016 | Amount | Private Equity Round - Concord Biotech | Valuation | Quadria Capital , Helix Investments |
|
| Jun, 2009 | Amount | Angel Round - Concord Biotech | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Concord Biotech
Concord Biotech has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include Quadria Capital, Helix Investments and Rakesh Jhunjhunwala. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare private equity investments focused on Asian markets.
|
Founded Year | Domain | Location | |
|
Private equity firm focused on acquisitions
|
Founded Year | Domain | Location | |
|
RJ
Rakesh Jhunjhunwala |
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Concord Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Concord Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Concord Biotech Comparisons
Competitors of Concord Biotech
Concord Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, BDR Pharmaceuticals Internationals, Aurobindo Pharma and Asymchem, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| domain | founded_year | HQ Location |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| domain | founded_year | HQ Location |
APIs and finished products are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| domain | founded_year | HQ Location |
APIs and peptides are developed and manufactured by Asymchem.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Concord Biotech
Frequently Asked Questions about Concord Biotech
When was Concord Biotech founded?
Concord Biotech was founded in 2000 and raised its 1st funding round 9 years after it was founded.
Where is Concord Biotech located?
Concord Biotech is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
How many employees does Concord Biotech have?
As of Mar 31, 2024, the latest employee count at Concord Biotech is 1,570.
What is the annual revenue of Concord Biotech?
Annual revenue of Concord Biotech is $137.85M as on Mar 31, 2024.
What does Concord Biotech do?
Founded in 2000 in Ahmedabad, India, the company operates as a CDMO in the pharmaceutical sector, specializing in research and production of fermentation-based semi-synthetic and synthetic APIs. Products cover immunosuppressants, antibiotics, oncology, antifungals, hypolipidemics, and enzymes. Services include strain improvement and contract fermentation manufacturing. Capabilities extend to solid orals, oral liquids, and suspensions compliant with global standards, with supplies provided internationally.
Who are the top competitors of Concord Biotech?
Concord Biotech's top competitors include BDR Pharmaceuticals Internationals, Almac Group and Indoco Remedies.
What products or services does Concord Biotech offer?
Concord Biotech offers APIs, Formulations, and Contract Research and Manufacturing.
Is Concord Biotech publicly traded?
Yes, Concord Biotech is publicly traded on NSE under the ticker symbol CONCORDBIO.
Who are Concord Biotech's investors?
Concord Biotech has 3 investors. Key investors include Quadria Capital, Helix Investments, and Rakesh Jhunjhunwala.
What is Concord Biotech's ticker symbol?
The ticker symbol of Concord Biotech is CONCORDBIO on NSE.
What is Concord Biotech's valuation?
The valuation of Concord Biotech is $352.41M as of Jul 2016.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.